NCT04590703View on ClinicalTrials.gov

A Follow-up Study to Evaluate the Safety of ALLO-ASC-DFU in ALLO-ASC-DFU-301 Clinical Trial

CompletedOBSERVATIONAL
Enrollment

73

Participants

Timeline

Start Date

June 24, 2020

Primary Completion Date

September 30, 2021

Study Completion Date

June 2, 2023

Conditions
Diabetic Foot Ulcer
Interventions
BIOLOGICAL

ALLO-ASC-DFU

Application of ALLO-ASC-DFU sheet to Diabetic Foot Ulcer. This study is a follow-up study without intervention.

PROCEDURE

Vehicle sheet

Application of Vehicle sheet to Diabetic Foot Ulcer. This study is a follow-up study without intervention.

Trial Locations (8)

13620

Seoul National University Bundang Hospital, Seongnam-si

14584

Soonchunhyang University Hospital, Bucheon-si

16499

Ajou University Medical Center, Suwon

42601

Keimyung University Dongsan Medical Center, Daegu

Unknown

Chungnam National University Hospital, Daejeon

01830

Nowon Eulji Medical Center, Eulji University, Seoul

05505

Asan Medical Center, Seoul

08308

Korea University Guro Hospital, Seoul

All Listed Sponsors
lead

Anterogen Co., Ltd.

INDUSTRY

NCT04590703 - A Follow-up Study to Evaluate the Safety of ALLO-ASC-DFU in ALLO-ASC-DFU-301 Clinical Trial | Biotech Hunter | Biotech Hunter